ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.639,28
-0,43%
S&P 500
5.213,78
-0,01%
US Dollar vs BRL
5,1499
0,15%
Bitcoin
60.859,89
-3,49%
Brent Oil
83,335
-0,73%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Axcella Health Inc (AXLA)

  7. Axcella Health Inc (AXLA) Notícias

AXLA

Axcella Health (AXLA)

Axcella Health Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXLA
DataHoraFonteTítuloCódigoCompanhia
22/12/202318:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXLAAxcella Health Inc
17/11/202310:47Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AXLAAxcella Health Inc
17/11/202310:28Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXLAAxcella Health Inc
06/11/202311:22Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AXLAAxcella Health Inc
14/09/202317:30Business WireAxcella Announces Reverse Stock Split Effective September 19, 2023NASDAQ:AXLAAxcella Health Inc
29/08/202309:00Business WireAxcella Granted Patent for Long COVID Fatigue TreatmentNASDAQ:AXLAAxcella Health Inc
18/08/202317:20Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AXLAAxcella Health Inc
03/08/202317:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXLAAxcella Health Inc
03/08/202308:30Business WireAxcella Reports Second Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
29/06/202317:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXLAAxcella Health Inc
04/05/202317:39Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AXLAAxcella Health Inc
04/05/202317:30Business WireAxcella Reports First Quarter Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
17/04/202309:00Business WireAxcella Announces Two Oral Presentations on AXA1125 for Long COVID Fatigue at ECCMID 2023NASDAQ:AXLAAxcella Health Inc
30/03/202317:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AXLAAxcella Health Inc
30/03/202309:00Business WireAxcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:AXLAAxcella Health Inc
03/03/202318:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXLAAxcella Health Inc
15/02/202318:10Business WireAxcella Announces FDA IND Clearance Supporting Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
14/02/202308:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AXLAAxcella Health Inc
09/02/202318:45Business WireAxcella Therapeutics to Participate in the SVB Securities’ 2023 Global Biopharma ConferenceNASDAQ:AXLAAxcella Health Inc
24/01/202311:20AllPennyStocks.comStrong Premarket Bid For This Micro CapNASDAQ:AXLAAxcella Health Inc
23/01/202319:03Dow Jones NewsAxcella Health Shares Surge 53% on U.K. Regulator Guidance on AXA1125 for Long Covid FatigueNASDAQ:AXLAAxcella Health Inc
23/01/202318:15Business WireAxcella Announces Regulatory Path to Registration of AXA1125 for Long COVID FatigueNASDAQ:AXLAAxcella Health Inc
14/12/202222:01Business WireAxcella Announces Program Reprioritization and Corporate RestructuringNASDAQ:AXLAAxcella Health Inc
04/11/202202:06TipRanksSVB Securities Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202209:05TipRanksNoble Financial Keeps Their Buy Rating on Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
02/11/202207:50TipRanksAnalysts Offer Insights on Healthcare Companies: Unity Biotechnology (UBX) and Axcella Health (AXLA)NASDAQ:AXLAAxcella Health Inc
18/10/202209:13TipRanksThis Insider Bought Axcella Health (NASDAQ:AXLA) Stock Worth $6MNASDAQ:AXLAAxcella Health Inc
17/10/202217:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXLAAxcella Health Inc
17/10/202217:32Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXLAAxcella Health Inc
13/10/202208:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AXLAAxcella Health Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXLA

Seu Histórico Recente

BOV
VVEO3
CM Hospitalar ON
BOV
IBOV
Índice Bovespa
BOV
IFCM3
Infracommerce Caxaas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
LUPA3
LUPATECH ON
BOV
PRIO3
PETRORIO ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
UNIP6
UNIPAR PNB
BOV
AZEV4
AZEVEDO PN
BOV
SGPS3
SPRINGS ON
BOV
COGN3
COGNA ON
BOV
HAGA3
HAGA ON
BOV
TELB4
TELEBRAS PN
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
SHOW3
TIME FOR FUN ON
BOV
CASH3
Meliuz S.A ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados